Evan Matros, MD
Plastic and Reconstructive Surgery · New York, NYNPI 1336260512
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (51.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Kls-martin L.p. accounts for 66.5% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $6,119, more than ten times the $32 reported in 2019. Among plastic and reconstructive surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 62 payments — averaging $249.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kls-martin L.p.$10K
- Johnson & Johnson$2K
- AbbVie$1K
- Integra Lifesciences Corporation$577
- Sientra, Inc.$533
- Mentor Worldwide LLC$285
- plus $949 from 8 others
What the payments were for
- Consulting fees$1,57010%
- Speaking & faculty fees$8,00052%
- Travel & lodging$2,28815%
- Food & beverage$3,59323%
- Entertainment$110%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kls-martin L.p. | 15 | $10,288 |
| Johnson & Johnson(2 entities) | 4 | $1,766 |
| AbbVie(2 entities) | 16 | $1,063 |
| Integra Lifesciences Corporation | 5 | $577 |
| Sientra, Inc. | 6 | $533 |
| Mentor Worldwide LLC | 5 | $285 |
| RTI Surgical, Inc | 2 | $250 |
| Alafair Biosciences, Inc. | 1 | $169 |
| Axogen | 1 | $157 |
| Kerecis Limited | 1 | $151 |
| Avita Medical Americas, LLC | 1 | $108 |
| Medical Device Business Services, Inc. | 3 | $78 |
| Surgical Specialties Corporation (US), Inc. (dba Corza Medical) | 1 | $25 |
| 3d Systems | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis SurgiClose$605
- ALLODERM$527
- SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$486
- TENOGLIDE$339
- NATRELLE SALINE-FILLED BREAST IMPLANTS$205
- VersaWrap$169
- AVANCE NERVE GRAFT$157
- AxoGuard Nerve Connector$157
- AxoGuard Nerve Protector$157
- AXOGUARD HA+ NERVE PROTECTOR$157
- AxoGuard Nerve Cap$157
- CORTIVA ALLOGRAFT DERMIS$155
- Kerecis GraftGuide$151
- SURGIMEND$121
- RECELL$108
- MENTOR MemoryGel Resterilizable Gel Sizer$108
How this compares
$15,461 in reported general payments places this provider in the 90th percentile of 219 plastic and reconstructive surgery providers in New York.
See all plastic and reconstructive surgery providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other plastic and reconstructive surgery in New York
- Robert GrantNew York$207K
- Christine RohdeNew York$180K
- Steven LevineNew York$108K
- Theodore DiktabanNew York$83K
- Lawrence BassNew York$37K
- Nicholas BastidasNew York$27K
- Philip MillerNew York$24K
- Joseph DisaNew York$21K
- Graham SchwarzNew York$16K
- Anna SteveNew York$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.